Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 20/11/2019
SIETES contiene 92834 citas

 1 a 20 de 48 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Anónimo. Towards better patient care: drugs to avoid in 2019. Prescrire Int 2019;39:abril. [Ref.ID 103075]
2. Cita con resumen
Montané E, Arellano AL, Sanz Y, Roca J, Farré M. Drug-related deaths in hospital inpatients: a retrospective cohort study. Br J Clin Pharmacol 2017;84:1. [Ref.ID 102184]
3. Cita con resumen
Anónimo. Bocéprévir: atteintes hématologiques graves. Prescrire 2014;34:350. [Ref.ID 97560]
4.Enlace a cita original
Jolink H, den Hartigh J, Visser LG, van Nieuwkoop C. Pancytopenia due to proguanil toxicity in a returning traveller with fever. Eur J Clin Pharmacol 2010;66:811-2. [Ref.ID 89062]
5.Enlace a cita original
Maurier F, Petitpain N, Guichard JF, Javot L, Tréchot P. Olanzapine and pancytopenia with severe folate deficiency. Eur J Clin Pharmacol 2010;66:531-3. [Ref.ID 88408]
6. Cita con resumen
Anónimo. Enrichir sa panoplie thérapeutique. Bilan de l'année 2008. Rhumatologie. Prescrire 2009;29:53-4. [Ref.ID 84827]
Anónimo. Colchicine: interactions graves. Prescrire 2008;28:267-70. [Ref.ID 82550]
8. Cita con resumen
Bertele V, Assisi A, Di Muzio V, Renzo D, Garattini S. New antirheumatic drugs: any real added value? A critical overview of regulatory criteria for their marketing approval. Eur J Clin Pharmacol 2007;63:879-89. [Ref.ID 80979]
9. Cita con resumen
Kontoghiorghes GJ. Deferasirox: uncertain future following renal failure fatalities, agranulocytosis and other toxicities. Expert Opin Drug Saf 2007;6:235-9. [Ref.ID 80688]
McEwen J, Purcell PM, Hill RL, Calcino LJ, Riley CG. The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate. Pharmacoepidemiol Drug Saf 2007;16:65-73. [Ref.ID 79223]
11. Cita con resumen
Brodsky RA, Jones RJ. Aplastic anaemia. Lancet 2005;365:1647-56. [Ref.ID 73693]
12.Tiene citas relacionadas
Leman P, Greene S. Commentary: Testing patients to allow tailored drug treatment. BMJ 2005;330:352. [Ref.ID 72880]
13.Tiene citas relacionadas
Konstantopoulou M, Belgi A, Griffiths KD, Seale JRC, Macfarlane AW. Azathioprine-induced pancytopenia in a patient with pompholyx and deficiency of erythrocyte thiopurine methyltransferase. BMJ 2005;330:350-2. [Ref.ID 72879]
Anónimo. Terbinafine and blood dyscrasias. WHO Drug Information 2004;18:273. [Ref.ID 72752]
15. Cita con resumen
Anónimo. Terbinafine et effets indésirables graves. Prescrire 2005;25:105. [Ref.ID 72710]
16. Cita con resumen
Anónimo. Australia sees blood dyscrasias with terbinafine. Scrip 2004;3004:15. [Ref.ID 71940]
Chan J, Sanders DC, Du L, Pillans P I. Leflunomide-associated pancytopenia wih or without methotrexate. Ann Pharmacother 2004;38:1206-11. [Ref.ID 70604]
Anónimo. Haematologic toxicity of two glycopeptides: vancomycin and teicoplanin. WHO Pharmaceuticals Newsletter 2003;3:10. [Ref.ID 66834]
Anónimo. Imatinib. Additional adverse reactions reported. Japan. WHO Pharmaceuticals Newsletter 2002;4:2. [Ref.ID 62995]
Seleccionar todas
 1 a 20 de 48 siguiente >>